MBIO:NASDAQ
Mustang Bio Inc
USD 0,46
arrow_upward
+0,39%(+0,0018) 1D
1 Okt., 15:29:25 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
USD 0,47
High
USD 0,47
Low
USD 0,46
Mkt. cap
3,54 m
Avg. vol.
24,30 k
Volume
15,09 k
52-wk high
USD 1,84
52-wk low
USD 0,46
EPS
-USD 0,46
Beta
2,05
Shares outstanding
6,73 m
No. of employees
4
Open
USD 0,47
High
USD 0,47
Low
USD 0,46
Mkt. cap
3,54 m
Avg. vol.
24,30 k
Volume
15,09 k
52-wk high
USD 1,84
52-wk low
USD 0,46
EPS
-USD 0,46
Beta
2,05
Shares outstanding
6,73 m
No. of employees
4
News stories
From web sources and news partners
PR Newswire
·
1 uur gelede
ADVASA HOLDINGS, INC. (NASDAQ: ADBT) INVESTOR ALERT: Hagens Berman Investigates Advasa Holdings, Inc. Following Sudden CFO Resignation Days After Nasdaq Direct Listing
ChartMill
·
32 minute gelede
What's going on in today's session: S&P500 movers
MarketBeat
·
30 minute gelede
Formula Systems (1985) (NASDAQ:FORTY) Sees Large Volume Increase - Time to Buy?
Seeking Alpha
·
1 uur gelede
The S&P’s strongest historical quarter starts with yields at multi decade highs
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, Verenigde State van Amerika
Sector-
Websitemustangbio.com